ASCO GI Archives

First results of the Checkmate 8HW study show first-line dual immunotherapy combination improves outcomes versus standard chemotherapy in metastatic colorectal cancer subtype

Checkmate 8HW is the first phase III study to assess first-line nivolumab plus ipilimumab in patients with unresectable microsatellite instability-high/mismatch…

First targeted radioligand therapy to demonstrate significant and clinically meaningful impact in first-line advanced gastroenteropancreatic neuroendocrine tumors

Results of the multi-center, randomized, comparator-controlled phase III NETTER-2 trial show that first-line treatment with radioligand therapy 177LU-DOTATATE in combination…

Josep Tabernero presents the improvements in survival of patients with metastatic colorectal cancer at ASCO GI Cancers Symposium

The annual ASCO Symposium on Gastrointestinal Cancers took place from 19-21 January. Josep Tabernero, Director of VHIO, presented the results…